p38 mitogen-activated protein kinase is activated and linked to TNF-α signaling in inflammatory bowel disease

Journal of Immunology

Volumn 168, Issue 10, 2002, Pages 5342-5351

  Waetzig, Georg H ^a   Seegert, Dirk ^a   Rosenstiel, Philip ^a   Nikolaus, Susanna ^a   Schreiber, Stefan ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INFLIXIMAB; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 0037093877     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.10.5342     Document Type: Article

References (58)

1. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
2. Role of cytokines in the pathogenesis of inflammatory bowel disease
3. Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease
4. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
5. Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD)
6. Enhanced secretion of tumour necrosis factor-α IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
7. Turnout necrosis factor α and interleukin 1β in relapse of Crohn's disease
8. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
9. A short-term study of chimeric monoclonal Ab cA2 to tumor necrosis factor α for Crohn's disease: Crohn's disease cA2 study group
10. Mechanisms in failure of infliximab for Crohn's disease
11. Tumor necrosis factor: Biology and therapeutic inhibitors
12. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
13. Linkage of inflammatory bowel disease to human chromosome 6p
14. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway
15. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
16. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
17. Mitogen-activated protein kinase pathways
18. The stress-activated protein kinase pathways
19. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
20. Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2- and p38 mitogen-activated protein kinase-dependent TNF-α gene expression
21. Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor α gene expression in T lymphocytes
22. Increased expression of IL-16 in inflammatory bowel disease
23. + macrophages
24. Mapping of a susceptibility locus for Crohn's disease on chromosome 16
25. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease
26. Classification of inflammatory bowel disease
27. Inflammatory bowel disease
28. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study
29. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
30. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)
31. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma
32. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma
33. Signal transduction by the c-Jun N-terminal kinase (JNK): From inflammation to development
34. Activation of p90RSK and cAMP response element binding protein in stimulated neutrophils: Novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade
35. Specificity and mechanism of action of some commonly used protein kinase inhibitors
36. Expression and function of the low-molecular-weight heat shock proteins
37. Differential activity and expression of mitogen-activated protein kinases in inflammatory bowel disease
38. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-β-dependent gene transcription in response to interferon-γ
39. p38-2, a novel mitogen-activated protein kinase with distinct properties
40. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation
41. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase
42. Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages
43. MAP kinase activation in macrophages
44. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
45. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
46. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models
47. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms
48. Regulation of monocyte IL-10 synthesis by endogenous IL-I and TNF-α: Role of the p38 and p42/44 mitogen-activated protein kinases
49. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-α (TNF- α) mRNA induction: Evidence for selective destabilization of TNF-α transcripts
50. Signalling to translational activation of tumour necrosis factor-α expression in human THP-1 cells
51. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-α therapy in rheumatoid arthritis
52. Inhibitory effect of growth hormone on TNF-α secretion and nuclear factor-κB translocation in lipopolysaccharide-stimulated human monocytes
53. The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts
54. + T cells
55. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 Ab
56. Role of p52 (NF-κB2) in LPS tolerance in a human B cell line
57. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in "reverse signalling."
58. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo